Anhui New Star Pharmaceutical Development Co., Ltd
Records under this name other than the patents Anhui New Star Pharmaceutical Development Co., Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 3 of 3 · Back to Anhui New Star Pharmaceutical Development Co., Ltd
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,814,709 | Bruton's tyrosine kinase inhibitor Lapsed on the fee record Ended Nov 14, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 14, 2025 | USPTO record |
| US 10,975,092 | Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof Lapsed on the fee record Ended Apr 13, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 13, 2025 | USPTO record |
| US 8,853,393 | Intermediate for preparing tapentadol or analogues thereof Lapsed on the fee record Ended Oct 7, 2022 · USPTO record | Lapsed on the fee record | Ended Oct 7, 2022 | USPTO record |